dentification of ferroptosis-related risk signature and correlation with the overall survival of ovarian cancer

Yibin Liu, Xin Xu, Jianlei Wu, Zhongkang Li, Ye Zhang, Xiaoxiao Zhang, Shike Shui, Hui Li, Tiantian Wang, Juan Zhai, Ruixia Guo, Yanpeng Tian, H Sung, J Ferlay, R Siegel, M Laversanne, I Soerjomataram, A Jemal, P Feng, Z Ge, Z Guo, L Lin, Q Yu, K Lu, P Choi, A Bahrampour, S Ng, S Liu, W Qiu, F Xie, R Liu, Y Zeng, C Zhou, Y Wang, X Li, Z Liu, Z Feng, H Wen, Z Jiang, X Ju, X Chen, A Laios, A Gryparis, D Dejong, R Hutson, G Theophilou, C Leach, T Hong, G Lei, N Wu, C Wan, M Keany, H Dong, L Al-Alem, U Pandya, S Lazo, A Farkkila, D Gulhan, J Casado, C Jacobson, H Nguyen, B Kochupurakkal, T Hirschhorn, B Stockwell, D Basuli, L Tesfay, Z Deng, B Paul, Y Yamamoto, G Ning, J Liang, D Wang, H Lin, H Yang, Y Zheng, L Jiang, N Kon, T Li, S Wang, T Su, H Hibshoosh, X Lang, M Green, Wang Yu, J Choi, J Jiang, L, Friedmann Angeli, J Krysko, D Conrad, M, Y You, Q Fan, J Huang, Y WuEuropean 2023 · DOI

TL;DR

This study identifies a novel 6-gene "ferroptosis-related risk signature" that can predict the prognosis of ovarian cancer patients. By analyzing publicly available genomic data, the researchers found that this signature effectively stratifies patients into high- and low-risk groups, with significant differences in overall survival, offering potential new therapeutic targets.

What Problem Does This Paper Address?

Ovarian cancer remains a deadly malignancy, with a high mortality rate, especially in advanced stages. Despite advances in treatment, improving patient outcomes is a persistent challenge. While ferroptosis, a form of programmed cell death driven by lipid peroxidation, has emerged as a potential therapeutic avenue in cancer, its specific role and implications in ovarian cancer were not well understood. This paper aims to bridge this knowledge gap by investigating ferroptosis-related genes and developing a predictive model for ovarian cancer prognosis.

Methods

The researchers utilized a multi-step approach:

  • Data Retrieval: They accessed molecular and clinical data for ovarian cancer patients from The Cancer Genome Atlas (TCGA) database.
  • Gene Identification: They identified differentially expressed ferroptosis-related genes by comparing gene expression profiles between normal ovarian tissues and ovarian cancer tissues. This involved using the DESeq2 package with specific thresholds for p-value and log fold change.
  • Risk Signature Construction: A key methodological contribution is the development of a multigene risk signature. This was achieved using the Least Absolute Shrinkage and Selection Operator (LASSO) Cox regression, a technique well-suited for feature selection and building predictive models in high-dimensional data.
  • Prognostic Validation: The prognostic value of the constructed signature was rigorously validated using several statistical methods:
  • Univariate and Multivariate Cox Regression: To assess the independent predictive power of the signature and other clinical factors.
  • Kaplan-Meier Survival Analysis: To compare survival curves between the high- and low-risk groups.
  • Principal Component Analysis (PCA) and t-distributed Stochastic Neighbor Embedding (t-SNE): To visualize the separation of patients into distinct groups based on the risk score.
  • Receiver Operating Characteristic (ROC) Curve Analysis: To evaluate the predictive accuracy and efficiency of the signature over time.
  • Functional Analysis: Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed to understand the biological functions and pathways associated with the identified ferroptosis-related genes. Single-sample Gene Set Enrichment Analysis (ssGSEA) was used to assess immune cell infiltration.

Datasets

The primary dataset used in this study was:

  • The Cancer Genome Atlas (TCGA) database: This provided molecular (RNA sequencing) and clinical data for ovarian cancer patients. The study utilized data from 88 normal ovarian tissues and 427 cancerous ovarian tissues.

Key Insights and Ideas

  • Ferroptosis as a Key Player in Ovarian Cancer: The study confirms that ferroptosis-related genes are differentially expressed in ovarian cancer and are significantly associated with patient prognosis, highlighting ferroptosis as a relevant biological process in this malignancy.
  • A Novel 6-Gene Predictive Signature: The development of a robust 6-gene risk signature (ALOX12, CRYAB, SLC7A11, HSBP1, STEAP3, and ACACA) provides a powerful tool for stratifying ovarian cancer patients based on their risk of poor survival.
  • Immune Microenvironment Link: Functional analysis revealed that the differentially expressed ferroptosis-related genes are enriched in pathways related to immune cells, suggesting a potential interplay between ferroptosis and the tumor immune microenvironment in ovarian cancer.
  • Potential Therapeutic Targets: The identified ferroptosis-related genes not only serve as prognostic markers but also represent potential therapeutic targets for developing new treatment strategies.

Key Results

  • Differentially Expressed Genes: The study identified 48 differentially expressed ferroptosis-related genes between normal and cancerous ovarian tissues, with 46 upregulated and 2 downregulated.
  • Six Core Genes Identified: Six genes (ALOX12, CRYAB, SLC7A11, HSBP1, STEAP3, and ACACA) were identified as significantly associated with ovarian cancer prognosis.
  • Risk Signature Performance: The 6-gene risk signature effectively stratified patients into high- and low-risk groups, with the low-risk group exhibiting significantly higher overall survival rates.
  • ROC Curve AUC Values: The predictive accuracy of the signature was demonstrated by Area Under the Curve (AUC) values of 0.684 at 1 year, 0.682 at 2 years, and 0.661 at 3 years.
  • Independent Prognostic Predictor: The risk score derived from the signature was identified as an independent prognostic predictor for ovarian cancer patients, even after controlling for other clinical factors like age.
  • Immune Cell Differences: Significant differences in immune cell subpopulations (e.g., macrophages, neutrophils, T-helper cells) were observed between the low- and high-risk groups.

Limitations and Future Work

The authors acknowledge several limitations:

  • Limited Normal Sample Size: The number of normal ovarian samples used for comparison was relatively small.
  • Lack of Experimental Validation: The study relied on bioinformatic analysis, and basic research experiments and validation using independent clinical samples are needed.
  • Unclear Mechanisms: The precise underlying mechanisms by which these ferroptosis-related genes influence ovarian cancer progression were not fully investigated.

Future work should focus on experimentally validating these findings, exploring the detailed molecular mechanisms, and investigating the therapeutic potential of targeting these ferroptosis-related genes in ovarian cancer.

Summary updated

Abstract

Ovarian cancer is a lethal female reproductive system malignancy. However, the physiological roles of ferroptosis in ovarian cancer remains unclear. In this study, biological information databases were screened to characterize and examine the differentially expressed ferroptosis-related genes between ovarian cancer and normal ovarian tissue, and to further investigate a novel risk signature for predicting the prognosis of ovarian cancer. Molecular and clinical data were retrieved from The Cancer Genome Atlas (TCGA) database. Based on these data, we identified differentially expressed ferroptosis-related genes, and construct a multigene risk signature by least absolute shrinkage and celection operator (LASSO) Cox regression to predict the prognosis of ovarian cancer. Univariate and multivariate Cox regression analysis were used to verify the prognostic value of the signature. We constructed a risk signature for ovarian cancer based on differentially expressed ferroptosis-related genes between normal ovarian samples and ovarian cancer samples. Referring to median risk score, patients were divided into high-risk group and low-risk group. We performed Cox regression analysis, principal component analysis (PCA), t-distributed stochastic neighbor embedding (t-SNE) analysis, Kaplan-Meier Survival analysis and receiver operating characteristic (ROC) curve to verify the accuracy of the predicted value of the risk signature. The overall survival rates in low-risk group was significantly higher than that in high-risk group. In addition, the area under the curve (AUC) of the ROC curve reached 0.684 at 1 year, 0.682 at 2 years and 0.661 at 3 years. Functional analysis indicated differentially expressed ferroptosis-related genes were enriched in immune-related cells. The ferroptosis-related genes signature could predict the prognosis of ovarian cancer. These genes might be potential therapeutic targets.
BibTeX
@inproceedings{liu2023dentification,
  author = {Yibin Liu and Xin Xu and Jianlei Wu and Zhongkang Li and Ye Zhang and Xiaoxiao Zhang and Shike Shui and Hui Li and Tiantian Wang and Juan Zhai and Ruixia Guo and Yanpeng Tian and H Sung and J Ferlay and R Siegel and M Laversanne and I Soerjomataram and A Jemal and P Feng and Z Ge and Z Guo and L Lin and Q Yu and K Lu and P Choi and A Bahrampour and S Ng and S Liu and W Qiu and F Xie and R Liu and Y Zeng and C Zhou and Y Wang and X Li and Z Liu and Z Feng and H Wen and Z Jiang and S Liu and X Ju and X Chen and A Laios and A Gryparis and D Dejong and R Hutson and G Theophilou and C Leach and T Hong and G Lei and X Chen and H Li and X Zhang and N Wu and C Wan and M Keany and H Dong and L Al-Alem and U Pandya and S Lazo and A Farkkila and D Gulhan and J Casado and C Jacobson and H Nguyen and B Kochupurakkal and T Hirschhorn and B Stockwell and D Basuli and L Tesfay and Z Deng and B Paul and Y Yamamoto and G Ning and J Liang and D Wang and H Lin and X Chen and H Yang and Y Zheng and L Jiang and N Kon and T Li and S Wang and T Su and H Hibshoosh and X Lang and M Green and Wang Yu and J Choi and J Jiang and L and Friedmann Angeli and J Krysko and D Conrad and M and Y You and Q Fan and J Huang and Y Wu},
  title = {{dentification of ferroptosis-related risk signature and correlation with the overall survival of ovarian cancer}},
  booktitle = {European},
  year = {2023},
  doi = {10.22514/ejgo.2023.023},
}
Figure